E. K. RYU
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Ubiquitin and proteasome pathways 9
- Protein Degradation and Inhibitors 4
- Chemical Synthesis and Analysis 4
-
- Synthesis and Characterization of Heterocyclic Compounds 5
- Oxidative Organic Chemistry Reactions 4
- Co-authors
- Malcolm MacCoss (2 shared papers)Yearn Seong Choe (10 shared papers)Byung‐Tae Kim (7 shared papers)Kyung-Han Lee (7 shared papers)Yong Choi (6 shared papers)Zhanhong Wu (2 shared papers)Xiaohong Chen (2 shared papers)Kai Chen (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Nuclear Medicine and Biology (4 papers)Biomaterials (3 papers)Amino Acids (3 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- South KoreaUnited StatesSwitzerland
In The Last Decade
E. K. RYU
61 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 111
- Molecular Medicine 92
- Microbiology 94
- Radiology, Nuclear Medicine and Imaging 200
- Molecular Biology 538
- Organic Chemistry 203
Countries citing papers authored by E. K. RYU
This map shows the geographic impact of E. K. RYU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. K. RYU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. K. RYU more than expected).
Fields of papers citing papers by E. K. RYU
This network shows the impact of papers produced by E. K. RYU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. K. RYU. The network helps show where E. K. RYU may publish in the future.
Co-authors
The 25 scholars most cited alongside E. K. RYU, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 174 | |
| 2 | 2008 | 123 | |
| 3 | 1979 | 115 | |
| 4 | 2016 | 62 | |
| 5 | 2013 | 51 | |
| 6 | Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability. | 1981 | 50 |
| 7 | 1996 | 37 | |
| 8 | 2013 | 35 | |
| 9 | 2020 | 29 | |
| 10 | 2016 | 21 | |
| 11 | 2004 | 21 | |
| 12 | 2011 | 20 | |
| 13 | 2012 | 20 | |
| 14 | 2014 | 18 | |
| 15 | 2004 | 17 | |
| 16 | 2019 | 17 | |
| 17 | 2005 | 16 | |
| 18 | 2007 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 2020 | 14 |
About E. K. RYU
E. K. RYU is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cell Biology and Microbiology, having authored 63 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Microtubule and mitosis dynamics (8 papers), Antimicrobial Peptides and Activities (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Protein Degradation and Inhibitors (4 papers), Chemical Synthesis and Analysis (4 papers), Oxidative Organic Chemistry Reactions (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Molecular Medicine (92 citations), Microbiology (94 citations), Radiology, Nuclear Medicine and Imaging (200 citations), Molecular Biology (538 citations) and Organic Chemistry (203 citations). E. K. RYU has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Malcolm MacCoss, Yearn Seong Choe, Byung‐Tae Kim, Kyung-Han Lee, Yong Choi, Zhanhong Wu, Xiaohong Chen, Kai Chen, Zibo Li and Jeong Kyu Bang. Their work appears in journals such as Journal of Medicinal Chemistry, Nuclear Medicine and Biology, Biomaterials, Amino Acids and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.